Literature DB >> 21628561

Lipooligosaccharide is required for the generation of infectious elementary bodies in Chlamydia trachomatis.

Bidong D Nguyen1, Doreen Cunningham, Xiaofei Liang, Xin Chen, Eric J Toone, Christian R H Raetz, Pei Zhou, Raphael H Valdivia.   

Abstract

Lipopolysaccharides (LPS) and lipooligosaccharides (LOS) are the main lipid components of bacterial outer membranes and are essential for cell viability in most Gram-negative bacteria. Here we show that small molecule inhibitors of LpxC [UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc deacetylase], the enzyme that catalyzes the first committed step in the biosynthesis of lipid A, block the synthesis of LOS in the obligate intracellular bacterial pathogen Chlamydia trachomatis. In the absence of LOS, Chlamydia remains viable and establishes a pathogenic vacuole ("inclusion") that supports robust bacterial replication. However, bacteria grown under these conditions were no longer infectious. In the presence of LpxC inhibitors, replicative reticulate bodies accumulated in enlarged inclusions but failed to express selected late-stage proteins and transition to elementary bodies, a Chlamydia developmental form that is required for invasion of mammalian cells. These findings suggest the presence of an outer membrane quality control system that regulates Chlamydia developmental transition to infectious elementary bodies and highlights the potential application of LpxC inhibitors as unique class of antichlamydial agents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21628561      PMCID: PMC3121853          DOI: 10.1073/pnas.1107478108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant.

Authors:  L Steeghs; H de Cock; E Evers; B Zomer; J Tommassen; P van der Ley
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis.

Authors:  Douglas A Whittington; Kristin M Rusche; Hyunshun Shin; Carol A Fierke; David W Christianson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-20       Impact factor: 11.205

3.  Chlamydia.

Authors:  Robert Belland; David M Ojcius; Gerald I Byrne
Journal:  Nat Rev Microbiol       Date:  2004-07       Impact factor: 60.633

Review 4.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

5.  Role of disulfide bonding in outer membrane structure and permeability in Chlamydia trachomatis.

Authors:  P Bavoil; A Ohlin; J Schachter
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Antibacterial activities and characterization of novel inhibitors of LpxC.

Authors:  John M Clements; Fanny Coignard; Ian Johnson; Stephen Chandler; Shilpa Palan; Andrew Waller; Jac Wijkmans; Michael G Hunter
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp.

Authors:  T P Hatch; I Allan; J H Pearce
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

8.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Lessons from an LPS-deficient Neisseria meningitidis mutant.

Authors:  Peter van der Ley; Liana Steeghs
Journal:  J Endotoxin Res       Date:  2003

10.  Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis.

Authors:  Robert J Belland; Guangming Zhong; Deborah D Crane; Daniel Hogan; Daniel Sturdevant; Jyotika Sharma; Wandy L Beatty; Harlan D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  22 in total

1.  Type II fatty acid synthesis is essential for the replication of Chlamydia trachomatis.

Authors:  Jiangwei Yao; Yasser M Abdelrahman; Rosanna M Robertson; John V Cox; Robert J Belland; Stephen W White; Charles O Rock
Journal:  J Biol Chem       Date:  2014-06-23       Impact factor: 5.157

2.  N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis.

Authors:  Sania Marwaha; Hanna Uvell; Olli Salin; Anders E G Lindgren; Jim Silver; Mikael Elofsson; Asa Gylfe
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

3.  Chlamydia Lipooligosaccharide Has Varied Direct and Indirect Roles in Evading both Innate and Adaptive Host Immune Responses.

Authors:  Xisheng Wang; Daniel D Rockey; Brian P Dolan
Journal:  Infect Immun       Date:  2020-07-21       Impact factor: 3.441

4.  Andrographolide inhibits intracellular Chlamydia trachomatis multiplication and reduces secretion of proinflammatory mediators produced by human epithelial cells.

Authors:  Ziyu Hua; Kyla M Frohlich; Yan Zhang; Xiaogeng Feng; Jiaxing Zhang; Li Shen
Journal:  Pathog Dis       Date:  2014-12-17       Impact factor: 3.166

5.  Colistin-resistant, lipopolysaccharide-deficient Acinetobacter baumannii responds to lipopolysaccharide loss through increased expression of genes involved in the synthesis and transport of lipoproteins, phospholipids, and poly-β-1,6-N-acetylglucosamine.

Authors:  Rebekah Henry; Nuwan Vithanage; Paul Harrison; Torsten Seemann; Scott Coutts; Jennifer H Moffatt; Roger L Nation; Jian Li; Marina Harper; Ben Adler; John D Boyce
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

Review 6.  Sensing the enemy, containing the threat: cell-autonomous immunity to Chlamydia trachomatis.

Authors:  Ryan Finethy; Jörn Coers
Journal:  FEMS Microbiol Rev       Date:  2016-11-01       Impact factor: 16.408

Review 7.  Structure, inhibition, and regulation of essential lipid A enzymes.

Authors:  Pei Zhou; Jinshi Zhao
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-12-09       Impact factor: 4.698

Review 8.  How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics.

Authors:  Jiangwei Yao; Charles O Rock
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

9.  Lipopolysaccharide-binding alkylpolyamine DS-96 inhibits Chlamydia trachomatis infection by blocking attachment and entry.

Authors:  Ichie Osaka; P Scott Hefty
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

10.  Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.

Authors:  Vítor Borges; Miguel Pinheiro; Minia Antelo; Daniel A Sampaio; Luís Vieira; Rita Ferreira; Alexandra Nunes; Filipe Almeida; Luís J Mota; Maria J Borrego; João P Gomes
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.